PathAI · 5 days ago
Senior Product Manager
PathAI is on a mission to improve patient outcomes with AI-powered pathology. They are seeking an experienced and driven Senior Product Manager, Platform Products who will play a pivotal role in advancing PathAI’s product strategy by owning and optimizing platform features and initiatives.
BiotechnologyHealth CareHealth Diagnostics
Responsibilities
Lead the development and implementation of platform product initiatives, collaborating closely with engineering, business, and design teams
Define clear product requirements, prioritize features, and work with cross-functional teams to ensure alignment and timely delivery
Analyze and translate user needs, market trends, and competitive insights into actionable platform features that enhance scalability and performance
Monitor and measure product performance, using insights to drive continuous improvement and value delivery
Communicate progress, learnings, and results to stakeholders, ensuring transparency and alignment with business objectives
Qualification
Required
5+ years experience in software product management
1-3 years experience in health tech
Strong analytical and problem-solving skills, with the ability to interpret data and make informed decisions
Excellent communication and collaboration abilities, with a track record of effective cross-functional partnerships
Preferred
Enterprise software (SaaS) experience preferred
Benefits
Eligible for Equity
Company
PathAI
PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.
H1B Sponsorship
PathAI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (20)
2023 (21)
2022 (29)
2021 (25)
2020 (7)
Funding
Current Stage
Late StageTotal Funding
$355.2MKey Investors
LabCorpGeneral AtlanticGeneral Catalyst
2024-05-01Acquired
2022-01-01Debt Financing· $100M
2021-05-18Series C· $165M
Recent News
2025-12-10
Company data provided by crunchbase